These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6896607)

  • 41. Dantrolene sodium in the treatment of malignant hypertension.
    Harrison GG; Chapman DC
    S Afr Med J; 1982 Oct; 62(15):503-4. PubMed ID: 7123413
    [No Abstract]   [Full Text] [Related]  

  • 42. Myoglobinuria versus hemoglobinuria.
    Materson BJ; Preston RA
    Hosp Pract (Off Ed); 1988 Oct; 23(10A):29-38. PubMed ID: 3141436
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of malignant hyperthermia with dantrolene].
    Landauer B
    Anaesthesist; 1980 Sep; 29(9):507-8. PubMed ID: 7468992
    [No Abstract]   [Full Text] [Related]  

  • 44. Malignant hyperthermia.
    Willner J
    Pediatr Ann; 1984 Feb; 13(2):128, 130, 132-4. PubMed ID: 6369232
    [No Abstract]   [Full Text] [Related]  

  • 45. Malignant hyperthermia. Dantrolene--dynamics and kinetics.
    Harrison GG
    Br J Anaesth; 1988 Feb; 60(3):279-86. PubMed ID: 3279988
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of malignant hyperthermia with dantrolene.
    Cooper JM; Jones HR; Williamson JW
    J Miss State Med Assoc; 1983 Oct; 24(10):259-61. PubMed ID: 6644804
    [No Abstract]   [Full Text] [Related]  

  • 47. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
    Alitalo I; Schulman A
    Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant hyperthermia in a myopathic child. Prolonged postoperative course requiring dantrolene.
    Fletcher R; Blennow G; Olsson AK; Ranklev E; Törnebrandt K
    Acta Anaesthesiol Scand; 1982 Oct; 26(5):435-8. PubMed ID: 7148363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant hyperthermia. Considerations for the ophthalmologist.
    Sedwick LA; Romano PE
    Surv Ophthalmol; 1981; 25(6):378-82. PubMed ID: 7245023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Malignant hyperthermia].
    Bouhajja B; Haddad F; Ben Ammar MS
    Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case report.
    Coons DJ; Hillman FJ; Marshall RW
    Am J Psychiatry; 1982 Jul; 139(7):944-5. PubMed ID: 6124135
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug treatment of malignant hyperpyrexia.
    Austin KL; Denborough MA
    Anaesth Intensive Care; 1977 Aug; 5(3):207-13. PubMed ID: 900461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dantrolene and the treatment of malignant hyperthermia.
    Hall GM
    Br J Anaesth; 1980 Sep; 52(9):847-9. PubMed ID: 7437223
    [No Abstract]   [Full Text] [Related]  

  • 54. [Experimental study of dantrolene sodium in anesthetic malignant hyperthermia in the pietrain-strain pig].
    Adnet P; Krivosic-Horber R; Guevart E; Theunynck D; Vincent A
    Cah Anesthesiol; 1986 Oct; 34(6):463-7. PubMed ID: 3801956
    [No Abstract]   [Full Text] [Related]  

  • 55. [Temporary registration of cases of peranesthetic malignant hyperthermia in France].
    Jacquot C; Alibeu JP; Gelas P; Stieglitz P
    Ann Fr Anesth Reanim; 1985; 4(3):318-20. PubMed ID: 4014803
    [No Abstract]   [Full Text] [Related]  

  • 56. Human malignant hyperthermia: awake episodes and correction by dantrolene.
    Gronert GA; Thompson RL; Onofrio BM
    Anesth Analg; 1980 May; 59(5):377-8. PubMed ID: 7189384
    [No Abstract]   [Full Text] [Related]  

  • 57. Dantrolene therapy for malignant hyperthermia.
    Hoff B; Taylor C; Kruel J
    Crit Care Med; 1980 Nov; 8(11):699-700. PubMed ID: 7428399
    [No Abstract]   [Full Text] [Related]  

  • 58. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
    Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
    Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.
    Watson CB; Reierson N; Norfleet EA
    Anesthesiology; 1986 Sep; 65(3):312-4. PubMed ID: 3752576
    [No Abstract]   [Full Text] [Related]  

  • 60. [Sodium dantrolene].
    Campos Suárez JM; Escolano Villén F; Catalá Puigbó E; Villar Landeira JM; Sanz Mazó M
    Rev Esp Anestesiol Reanim; 1985; 32(4):179-83. PubMed ID: 3901158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.